Evidence map›Paper›PMID 30909602›Full record

ReviewCells2019

2,4 Dinitrophenol as Medicine.

John G Geisler

Open access · goldAbstract readReview
In one paragraph

Review in Cells, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 102 citations in OpenAlex.

  1. Review
  2. Article
  3. Mechanisms of Protection Against Oxidative Stress During Hibernation.International journal of molecular sciences · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Replenishment of mitochondrial NaMaterials today. Bio · 2024
    Article
  13. Targeting mitochondrial CaThe Journal of physiology · 2024
    Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

John G GeislerMitochon Pharmaceuticals, Inc., 970 Cross Lane, Blue Bell, PA 19422, USA. jgeisler@mitochonpharma.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the sanctity of pure drug discovery, objective reasoning can become clouded when pursuing ideas that appear unorthodox, but are spot on physiologically. To put this into historical perspective, it was an unorthodox idea in the 1950's to suggest that warfarin, a rat poison, could be repositioned into a breakthrough drug in humans to protect against strokes as a blood thinner. Yet it was approved in 1954 as Coumadin

Indexed as

Medicine2,4-DinitrophenolAdenosine TriphosphateAnimalsCalciumCognitionHumansReactive Oxygen Species2,4-DinitrophenolAdenosine TriphosphateCalciumReactive Oxygen Species2,4-dinitrophenol (DNP)anti-agingBrain-derived neurotrophic factor (BDNF)Duchenne Muscular DystrophyHuntington’s Diseasemetabesitymitochondrial uncouplerMultiple SclerosisneurodegenerationTraumatic Brain Injury

Identifiers

PMID30909602
PMCPMC6468406
OpenAlexW2924938564

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.